FDA Approves Risdiplam, Now Known as Evrysdi, The First Oral Treatment For All SMA Types

SMA News Today’s multimedia associate, Price Wooldridge, discusses the FDA approval of risdiplam, now known as Evrysdi, as the first oral treatment for all SMA types.

This flash briefing is a summary of the article that was written by SMA News Today. To read the article in its entirety, please click on the following link: https://smanewstoday.com/2020/08/07/fda-approves-evrysdi-risdiplam-first-oral-sma-treatment/

Also, DeAnn Runge describes the dreaded task of finding a new caregiver.

Are you interested in learning more about spinal muscular atrophy? If so, please visit https://smanewstoday.com/